[Growth retardation in histiocytosis X. Evaluation of anterior pituitary function].
Calzada
L D
LD
Chaussain
J L
JL
Job
J C
JC
D017668:Age of Onset; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D015984:Causality; D002648:Child; D003919:Diabetes Insipidus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006130:Growth Disorders / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D019382:Human Growth Hormone / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010901:Pituitary Function Tests / Q000379:methods*; D011241:Prednisone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D019382:Human Growth Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011241:Prednisone